LoginSignup
Recordati logo

Recordati Stock

StockStock
ISIN: IT0003828271
Ticker: REC
IT0003828271
REC

Price

Historical dividends and forecast

All dividend data

Recordati has so far distributed $0.682 in 2024. The next dividend will be paid on 20.11.2024

$0.656

CHART BY

Frequently asked questions

What is Recordati's market capitalization?

The market capitalization of Recordati is $11.45B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Recordati's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Recordati is 26.52. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Recordati?

Recordati's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.064. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Recordati's stock?

Currently, 11 analysts cover Recordati's stock, with a consensus target price of $55.38. Analyst ratings provide insights into the stock's expected performance.

What is Recordati's revenue over the trailing twelve months?

Over the trailing twelve months, Recordati reported a revenue of $2.39B.

Is Recordati paying dividends?

Yes, Recordati is paying dividends. The next payment is scheduled for 20.11.2024, with an expected amount of .

What is the EBITDA for Recordati?

Recordati's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $849.88M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Recordati?

Recordati has a free cash flow of $238.96M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Recordati's stock?

The 5-year beta for Recordati is 0.30. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Recordati have, and what sector and industry does it belong to?

Recordati employs approximately 4,455 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Recordati's shares?

The free float of Recordati is 97.87M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $11.45B

5Y beta

 0.30

EPS (TTM)

 $2.064

Free Float

 97.87M

P/E ratio (TTM)

 26.52

Revenue (TTM)

 $2.39B

EBITDA (TTM)

 $849.88M

Free Cashflow (TTM)

 $238.96M

Pricing

1D span
$53.71$55.12
52W span
$67.19$69.77

Analyst Ratings

The price target is $55.38 and the stock is covered by 11 analysts.

Buy

4

Hold

5

Sell

2

Information

Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.

4,455

Biotechnology & Drugs

Health Care

Identifier

ISIN

IT0003828271

Primary Ticker

REC

Knockouts

Join the conversation
Sign upLogin